Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.
Vasculogenic mimicry (VM) is a newly-defined tumor microcirculation pattern in highly aggressive malignant tumors. We recently reported tumor growth and VM formation of gallbladder cancers through the contribution of the ephrin type a receptor 2 (EphA2)/focal adhesion kinase (FAK)/Paxillin signaling...
Guardado en:
Autores principales: | Hui Wang, Wei Sun, Wen-Zhong Zhang, Chun-Yan Ge, Jing-Tao Zhang, Zhong-Yan Liu, Yue-Zu Fan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01986b242346422795eb59d716660701 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma
por: Junying Sun, et al.
Publicado: (2017) -
Structural and functional identification of vasculogenic mimicry in vitro
por: Dusan Racordon, et al.
Publicado: (2017) -
Vasculogenic mimicry in small cell lung cancer
por: Stuart C. Williamson, et al.
Publicado: (2016) -
Vasculogenic mimicry formation in EBV-associated epithelial malignancies
por: Tong Xiang, et al.
Publicado: (2018) -
Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma
por: Ju RJ, et al.
Publicado: (2016)